Found: 20
Select item for more details and to access through your institution.
Cereblon expression in multiple myeloma: not ready for prime time.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 2, p. 282, doi. 10.1111/bjh.12478
- By:
- Publication type:
- Article
Classify Hyperdiploidy Status of Multiple Myeloma Patients Using Gene Expression Profiles.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0058809
- By:
- Publication type:
- Article
Genomic landscape and chronological reconstruction of driver events in multiple myeloma.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-11680-1
- By:
- Publication type:
- Article
Constraints on signaling network logic reveal functional subgraphs on Multiple Myeloma OMIC data.
- Published in:
- BMC Systems Biology, 2018, v. 12, n. Suppl 3, p. 1, doi. 10.1186/s12918-018-0551-4
- By:
- Publication type:
- Article
A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 116, n. 3, p. 509, doi. 10.1007/s10549-008-0250-8
- By:
- Publication type:
- Article
Recurrent somatic Alterations in the Non-Coding Genome Alter Gene Expression Levels and Correlate With Clinical Outcome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e12, doi. 10.1016/j.clml.2019.09.017
- By:
- Publication type:
- Article
A First In-Depth Analysis of Alternate Splicing Landscape in Multiple Myeloma with Significant Potential Biological and Clinical Implications.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e13, doi. 10.1016/j.clml.2019.09.018
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 257, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genome-wide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genome-wide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 12, p. 1, doi. 10.1038/s41408-022-00759-6
- By:
- Publication type:
- Article
DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma.
- Published in:
- Clinical Epigenetics, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13148-020-00953-y
- By:
- Publication type:
- Article
Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 446, doi. 10.1002/hon.2750
- By:
- Publication type:
- Article
Genomic patterns of progression in smoldering multiple myeloma.
- Published in:
- Nature Communications, 2018, v. 9, p. 1, doi. 10.1038/s41467-018-05058-y
- By:
- Publication type:
- Article
The shaping and functional consequences of the dosage effect landscape in multiple myeloma.
- Published in:
- BMC Genomics, 2013, v. 14, n. 1, p. 672, doi. 10.1186/1471-2164-14-672
- By:
- Publication type:
- Article
Inhibition of mTORC1 activity by REDD1 induction in myeloma cells resistant to bortezomib cytotoxicity.
- Published in:
- Cancer Science, 2010, v. 101, n. 4, p. 889, doi. 10.1111/j.1349-7006.2009.01467.x
- By:
- Publication type:
- Article